Douglas C. Lane & Associates’s Amgen AMGN Stock Holding History

Douglas C. Lane & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$56.2M	Sell	346,380 -6,413	-2%	-$1.01M	1.52%	16
2015 Q3	$48.8M	Sell	352,793 -10,652	-3%	-$1.68M	1.39%	23
2015 Q2	$55.8M	Sell	363,445 -5,679	-2%	-$910K	1.5%	18
2015 Q1	$59M	Sell	369,124 -1,990	-0.5%	-$313K	1.55%	15
2014 Q4	$59.1M	Sell	371,114 -4,239	-1%	-$661K	1.6%	13
2014 Q3	$52.7M	Buy	375,353 +1,107	+0.3%	+$145K	1.57%	15
2014 Q2	$44.3M	Buy	374,246 +4,288	+1%	+$496K	1.34%	21
2014 Q1	$45.6M	Sell	369,958 -1,016	-0.3%	-$123K	1.46%	18
2013 Q4	$42.3M	Sell	370,974 -4,375	-1%	-$498K	1.4%	21
2013 Q3	$42M	Sell	375,349 -2,112	-0.6%	-$229K	1.53%	13
2013 Q2	$37.2M	Buy	+377,461	New	+$39.2M	1.45%	18

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Douglas C. Lane & Associates's AMGN Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Amgen (AMGN) stake by 1.8% in Q4 2015, selling an estimated $1.01M and leaving 346,380 shares worth $56.2M. The position accounts for 1.52% of the portfolio, ranked #16.

Douglas C. Lane & Associates first reported a position in AMGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $59.1M in Q4 2014. 1,454 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

Douglas C. Lane & Associates held 346,380 shares of Amgen worth $56.2M as of Q4 2015.
Douglas C. Lane & Associates sold 6,413 Amgen shares in Q4 2015, an estimated $1.01M.
Amgen made up 1.52% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #16 holding.
Douglas C. Lane & Associates first reported a position in Amgen in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's Amgen position peaked at $59.1M in Q4 2014.
1,454 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.